Cargando…
Molecular Mode of Action of TRAIL Receptor Agonists—Common Principles and Their Translational Exploitation
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its death receptors TRAILR1/death receptor 4 (DR4) and TRAILR2/DR5 trigger cell death in many cancer cells but rarely exert cytotoxic activity on non-transformed cells. Against this background, a variety of recombinant TRAIL variant...
Autor principal: | Wajant, Harald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678900/ https://www.ncbi.nlm.nih.gov/pubmed/31284696 http://dx.doi.org/10.3390/cancers11070954 |
Ejemplares similares
-
Editorial: TNFRSF agonists: mode of action and therapeutic opportunities
por: Obermajer, Nataša, et al.
Publicado: (2023) -
Principles of antibody-mediated TNF receptor activation
por: Wajant, H
Publicado: (2015) -
Blaze a New Trail: Plant Virus Xylem Exploitation
por: Sun, Yong-Duo, et al.
Publicado: (2022) -
Incretin therapies: highlighting common features and differences in the modes of action of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors
por: Nauck, M.
Publicado: (2016) -
Relationship between the agonist activity of synthetic ligands of TRAIL-R2 and their cell surface binding modes
por: Chekkat, Neila, et al.
Publicado: (2018)